Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

Journal of Photochemistry and Photobiology B: Biology

Volumn 95, Issue 2, 2009, Pages 71-80

  Cassidy, Corona M ^a   Tunney, Michael M ^a   McCarron, Paul A ^b   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Drug delivery; Photodynamic antimicrobial chemotherapy; Targeting

Indexed keywords

3,7 BIS(DI N BUTYLAMINO)PHENOTHIAZIN 5 IUM BROMIDE; 5 PHENYL 10,15,20 TRIS(N METHYL 4 PYRIDYL)PORPHYRIN CHLORIDE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTIFUNGAL AGENT; BROMINE DERIVATIVE; METHYLENE BLUE; MONOCLONAL ANTIBODY; NEUTRAL RED; PHOTOSENSITIZING AGENT; PLACEBO; PORPHYRIN DERIVATIVE; PPA 904; PROFLAVINE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CYSTIC FIBROSIS; DISINFECTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; INFECTION; IRRADIATION; LEG ULCER; LUNG INFECTION; MAXILLA SINUSITIS; MEDICAL INSTRUMENTATION; MULTIDRUG RESISTANCE; NONHUMAN; ONYCHOMYCOSIS; PHOTODYNAMIC ANTIMICROBIAL CHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTOZOON; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; THRUSH; VERRUCA VULGARIS; WOUND HEALING; WOUND INFECTION;

CHEMISTRY, PHARMACEUTICAL; DISINFECTION; DRUG DELIVERY SYSTEMS; HUMANS; INFECTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

FUNGI; NEGIBACTERIA; POSIBACTERIA; PROTOZOA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 64149087226     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.01.005     Document Type: Review

References (84)

1. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother. 42 (1998) 13-28
2. Donnelly R.F., McCarron P.A., and Tunney M.M. Antifungal photodynamic therapy. Microbiol. Res. 163 (2008) 1-12
3. Martin J., Mehta D.K., Jordan B., MacFarlane C.R., Ryan R.S., and Wagle S.M. British National Formulary. 53rd ed. (2007), BMJ Publishing Group Ltd. p. 458
4. Griffiths M.A., Wren B.W., and Wilson M. Killing of methicillin-resistant Staphylococcus aureus in vitro using aluminium disulphonated phthalocyanine, a light-activated antimicrobial agent. J. Antimicrob. Chemother. 40 (1997) 873-876
5. Donnelly R.F., McCarron P.A., Cassidy C.M., Elborn J.S., and Tunney M.M. Delivery of photosensitizers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. J. Control. Release 117 (2007) 217-226
6. Sharma M., Visai L., Bragheri F., Cristiani I., Gupta P.K., and Speziale P. Toluidine blue-mediated photodynamic effects on Staphylococcal biofilms. Antimicrob. Agents Chemother. 52 (2008) 299-305
7. Tang H.M., Hamblin M.R., and Yow C.M. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J. Infect. Chemother. 13 (2007) 87-91
8. Smetana Z., Ben-Hur E., Mendelson E., Salzberg S., Wagner P., and Malik Z. Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. J. Photochem. Photobiol. B 44 (1998) 77-83
9. Smetana Z., Mendelson E., Manor J., van Lier J.E., Ben-Hur E., Salzberg S., et al. Photodynamic inactivation of herpes viruses with phthalocyanine derivatives. J. Photochem. Photobiol. B 22 (1994) 37-43
10. Schagen F.H., Moor A.C., Cheong S.C., Cramer S.J., van Ormondt H., van der Eb A.J., et al. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation. Gene Ther. 6 (1999) 873-881
11. Roamgnoli C., Mares D., Sacchetti G., and Bruni A. The photodynamic effect of 5-(4-hydroxy-1-butinyl)-2,2-bithienyl on dermatophytes. Mycol. Res. 12 (1998) 1519-1524
12. Donnelly R.F., McCarron P.A., Lightowler J.M., and Woolfson A.D. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J. Control. Release 103 (2005) 381-392
13. Soukos N.S., Wilson M., Burns T., and Speight P.M. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg. Med. 18 (1996) 253-259
14. Zeina B., Greenman J., Corry D., and Purcell W.M. Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro. Br. J. Dermatol. 148 (2003) 229-232
15. Horfelt C., Stenquist B., Larko O., Faergemann J., and Wennberg A.M. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. Acta Derm. Venereol. 87 (2007) 325-329
16. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using methyl aminolevulinate: a blinded, randomized, controlled trial. Br. J. Dermatol. 154 (2006) 969-976
17. Hongcharu W., Taylor C.R., Chang Y., Aghassi D., Suthamjariya K., and Anderson R.R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol. 115 (2000) 183-192
18. Itoh Y., Ninomiya Y., Tajima S., and Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch. Dermatol. 136 (2000) 1093-1095
19. Stender I.M., Na R., Fogh H., Gluud C., and Wulf H.C. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 355 (2000) 963-966
20. Stender I.M., Lock-Andersen J., and Wulf H.C. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolevulinic acid: a pilot study. Clin. Exp. Dermatol. 24 (1999) 154-159
21. Wang Y.S., Tay Y.K., Kwok C., and Tan E. Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population. Int. J. Dermatol. 46 (2007) 1180-1184
22. Stahl D., Veien N.K., and Wulf H.C. Photodynamic inactivation of virus warts: a controlled clinical trial. Clin. Exp. Dermatol. 4 (1979) 81-85
23. Lambrechts S.A., Demidova T.N., Aalders M.C., Hasan T., and Hamblin M.R. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem. Photobiol. Sci. 4 (2005) 503-509
24. Orenstein A., Klein D., Kopolovic J., Winkler E., Malik Z., Keller N., et al. The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol. Med. Microbiol. 19 (1997) 307-314
25. Gad F., Zahra T., Francis K.P., Hasan T., and Hamblin M.R. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem. Photobiol. Sci. 3 (2004) 451-458
26. Embleton M.L., Nair S.P., Heywood W., Menon D.C., Cookson B.D., and Wilson M. Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 49 (2005) 3690-3696
27. McCarron P.A., Donnelly R.F., Andrews G.P., and Woolfson A.D. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J. Pharm. Sci. 94 (2005) 1756-1771
28. Taub A.F. Photodynamic therapy for the treatment of acne: a pilot study. J. Drugs Dermatol. 3 (2004) S10-S14
29. DUSA Pharmaceuticals, Product Information for Levulan Kerastick Topical Solution, , 2008.
30. G. Lee, R. Szeimies, Dermal application system for acid, 10/332547, 2005.
31. J. Zhang, L. Rigby, W. Hull, Methods and formulations for photodynamic therapy, 10208662, 2002.
32. Kacerovska D., Pizinger K., Kumpova M., and Cetkovska P. Genital warts treated by photodynamic therapy. Skinmed. 6 (2007) 295-297
33. Wang X.L., Wang H.W., Wang H.S., Xu S.Z., Liao K.H., and Hillemanns P. Topical 5-aminolevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br. J. Dermatol. 151 (2004) 880-885
34. Veien N.K., Genner J., Brodthagen H., and Wettermark G. Photodynamic inactivation of verrucae vulgares. II. Acta Derm. Venereol. 57 (1977) 445-447
35. Fabbrocini G., DiCostanzo M.P., Riccardo A.M., Quarto M., Colasanti A., Roberti G., et al. Photodynamic therapy with topical delta-aminolevulinic acid for the treatment of plantar warts. J. Photochem. Photobiol. B 61 (2001) 30-34
36. Photopharmica website, Photopharmica targets infected wounds with its photodynamic therapy, p.2. Accessed 14/01/2008. Available from: .
37. Wong T.W., Wang Y.Y., Sheu H.M., and Chuang Y.C. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob. Agents Chemother. 49 (2005) 895-902
38. Hamblin M.R., Zahra T., Contag C.H., McManus A.T., and Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J. Infect. Dis. 187 (2003) 1717-1725
39. Hamblin M.R., O'Donnell D.A., Murthy N., Contag C.H., and Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 75 (2002) 51-57
40. Berthiaume F., Reiken S.R., Toner M., Tompkins R.G., and Yarmush M.L. Antibody-targeted photolysis of bacteria in vivo. Biotechnology (NY) 12 (1994) 703-706
41. Jones S.G., Edwards R., and Thomas D.W. Inflammation and wound healing: the role of bacteria in the immuno-regulation of wound healing. Int. J. Low Extrem. Wounds 3 (2004) 201-208
42. Hamblin M.R., and Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem. Photobiol. Sci. 3 (2004) 436-450
43. Barrow P.A., and Soothill J.S. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 5 (1997) 268-271
44. S.B. Brown, C.C. O'Grady, J. Griffiths, K.J. Mellish, D.I. Vernon, Biologically active methylene blue derivatives, 10/723,420, pp. 1-37 (13/5/2008).
45. Valenta C., Auner B.G., and Loibl I. Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation. J. Control. Release 107 (2005) 495-501
46. Bender J., Ericson M.B., Merclin N., Iani V., Rosen A., Engstrom S., et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control. Release 106 (2005) 350-360
47. Genina E.A., Bashkatov A.N., Chikina E.E., Knyazev A.B., Mareev O.V., and Tuchin V.V. Methylene blue mediated laser therapy of maxillary sinusitis. Laser Phys. 16 (2006) 1128-1133
48. Zohar Y., Talmi Y.P., Finkelstein Y., and Shem-Tov Y. Use of a braunula for maxillary sinus irrigation. J. Laryngol. Otol. 103 (1989) 279-280
49. B. Love, Destiny Pharma website, 2008 (08/08/2008).
50. W. Love, D. Brundish, W. Rhys-Williams, X.D. Feng, B. Pugin, Porphyrin derivatives and their use in photodynamic therapy, 10744863, 2003.
51. Teichert M.C., Jones J.W., Usacheva M.N., and Biel M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93 (2002) 155-160
52. Donnelly R.F., McCarron P.A., Tunney M.M., and Woolfson A.D. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J. Photochem. Photobiol. B 86 (2007) 59-69
53. British Society of Periodontology, Periodontal disease and treatment, 2008 (26/9/2008).
54. Dobson J., and Wilson M. Sensitization of oral bacteria in biofilms to killing by light from a low-power laser. Arch. Oral Biol. 37 (1992) 883-887
55. Lauro F.M., Pretto P., Covolo L., Jori G., and Bertoloni G. Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem. Photobiol. Sci. 1 (2002) 468-470
56. Bhatti M., MacRobert A., Meghji S., Henderson B., and Wilson M. Effect of dosimetric and physiological factors on the lethal photosensitization of Porphyromonas gingivalis in vitro. Photochem. Photobiol. 65 (1997) 1026-1031
57. Wood S., Nattress B., Kirkham J., Shore R., Brookes S., Griffiths J., et al. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J. Photochem. Photobiol. B 50 (1999) 1-7
58. Komerik N., Nakanishi H., MacRobert A.J., Henderson B., Speight P., and Wilson M. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob. Agents Chemother. 47 (2003) 932-940
59. Sigusch B.W., Pfitzner A., Albrecht V., and Glockmann E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J. Periodontol. 76 (2005) 1100-1105
60. Andersen R., Loebel N., Hammond D., and Wilson M. Treatment of periodontal disease by photodisinfection compared to scaling and root planing. J. Clin. Dent. 18 (2007) 34-38
61. Bonsor S.J., Nichol R., Reid T.M., and Pearson G.J. Microbiological evaluation of photo-activated disinfection in endodontics (an in vivo study). Br. Dent. J. 200 (2006) 337-341 (discussion 329)
62. Jones D.S., Lorimer C.J., Andrews G.P., McCoy C.P., and Gorman S.P. An examination of the thermorheological and drug release properties of zinc tetraphenylporphyrin-containing thermoresponsive hydrogels, designed as light activated antimicrobial implants. Chem. Eng. Sci. 62 (2007) 990-999
63. Politis C., Kavallierou L., Hantziara S., Katsea P., Triantaphylou V., Richardson C., et al. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience. Vox Sang. 92 (2007) 319-326
64. Williamson L.M., Cardigan R., and Prowse C.V. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?. Transfusion 43 (2003) 1322-1329
65. Depasse F., Sensebé L., Seghatchian J., Andreu G., and Samama M. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. Transfus. Apher. Sci. 33 (2005) 63-69
66. Wainwright M. The emerging chemistry of blood product disinfection. Chem. Soc. Rev. 31 (2002) 128-136
67. Wainwright M., Mohr H., and Walker W.H. Phenothiazinium derivatives for pathogen inactivation in blood products. J. Photochem. Photobiol. B 86 (2007) 45-58
68. Wainwright M. Pathogen inactivation in blood products. Curr. Med. Chem. 9 (2002) 127-143
69. Wainwright M. Methylene blue derivatives-suitable photoantimicrobials for blood product disinfection?. Int. J. Antimicrob. Agents 16 (2000) 381-394
70. Brady C., Bell S.E., Parsons C., Gorman S.P., Jones D.S., and McCoy C.P. Novel porphyrin-incorporated hydrogels for photoactive intraocular lens biomaterials. J. Phys. Chem. B 111 (2007) 527-534
71. Baroli B. Hydrogels for tissue engineering and delivery of tissue-inducing substances. J. Pharm. Sci. 96 (2007) 2197-2223
72. W.G. Love, M.J. Cook, D.A. Russell, Porphyrin derivatives: their use in photodynamic therapy and the medical devices containing them, 09/786,139, pp. 1-32 (7/10/2003).
73. Bonnett R., Buckley D.G., Burrow T., Galia A.B., Saville B., and Songca S.P. Photobactericidal materials based on porphyrins and phthalocyanines. J. Mater. Chem. 3 (1993) 323-324
74. Wilson M. Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect. Control Hosp. Epidemiol. 24 (2003) 782-784
75. Decraene V., Pratten J., and Wilson M. Cellulose acetate containing toluidine blue and rose bengal is an effective antimicrobial coating when exposed to white light. Appl. Environ. Microbiol. 72 (2006) 4436-4439
76. Cunningham R., and Dial S. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?. J. Hosp. Infect. 70 (2008) 1-6
77. Wainwright M., Byrne M.N., and Gattrell M.A. Phenothiazinium-based photobactericidal materials. J. Photochem. Photobiol. B 84 (2006) 227-230
78. Bozja J., Sherrill J., Michielsen S., and Stojiljkovic I. Porphyrin-based, light-activated antimicrobial materials. J. Polym. Sci., Polym. Chem. 41 (2003) 2297-2303
79. DeMarco C.E., Cushing L.A., Frempong-Manso E., Seo S.M., Jaravaza T.A., and Kaatz G.W. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 51 (2007) 3235-3239
80. Bezman S.A., Burtis P.A., Izod T.P., and Thayer M.A. Photodynamic inactivation of E. coli by rose bengal immobilized on polystyrene beads. Photochem. Photobiol. 28 (1978) 325-329
81. Schaap A.P., Thayer A.L., Bloosey E.C., and Neckers D.C. Polymer-based sensitizers for photooxidations II. J. Am. Chem. Soc. 97 (1975) 3741-3745
82. Savino A., and Angeli G. Photodynamic inactivation of E. coli by immobilized or coated dyes on insoluble supports. Water Res. 19 (1985) 1465-1469
83. Bonnett R., Krysteva M.A., Lalov I.G., and Artarsky S.V. Water disinfection using photosensitizers immobilized on chitosan. Water Res. 40 (2006) 1269-1275
84. R.F. Donnelly, C.M. Cassidy, R.G. Loughlin, A. Brown, M.M. Tunney, M.G. Jenkins, P.A. McCarron. Delivery of methylene blue and meso-tetra(N-methyl-4-pyridyl) porphine tetra tosylate from crosslinked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds, J. Photochem. Photobiol. B: Biol. submitted for publication.